+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkins Lymphoma: Final Results of the GHSG HD7 Trial



Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkins Lymphoma: Final Results of the GHSG HD7 Trial



Yearbook of Oncology 2008: 128-130




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063735946

Download citation: RISBibTeXText

DOI: 10.1016/s1040-1741(08)79113-9


Related references

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. Journal of Clinical Oncology 25(23): 3495-3502, 2007

Two Cycles ABVD Plus Extended Field Radiotherapy Is Superior to Radiotherapy Alone in Early Stage Hodgkins Disease Results of the German Hodgkins Lymphoma Study Group Trial HD7. Blood 100(11): Abstract No 341, 2002

Chemotherapy vs radiotherapy for remission consolidation after three double cycles of cyclophosphamide vincristine procarbazine prednisone copp and doxorubicin bleomycin vinblastine dacarbazine abvd a randomized trial in patients with stages iiib iv hodgkins lymphoma. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 613, 1990

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine or epirubicin, bleomycin, vinblastine, and methotrexate plus extended field radiation therapy in early and intermediate Hodgkin disease 10-Year results of a randomized trial. Blood 103(1): 58-66, 2004

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial. Blood 103(1): 58-66, 2004

Second interim analysis of the HD7 trial of the GHSG 2 Cycles ABVD plus extended field radiotherapy is more effective than radiotherapy alone in early stage HD. Blood 94(10 Suppl. 1 Part 2): 268b, 1999

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial. Cancer 95(10): 2169-2179, 2002

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. British Journal of Haematology 185(1): 42-52, 2019

Biophysical analysis of acute toxicity of radiotherapy in Hodgkins lymphoma a comparison between extended field and involved field radiotherapy based on the data of the german hodgkin study group (GHSG). International Journal of Radiation Oncology*biology*physics 60: S219-S219, 2004

Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine alone vs ABVD+radiation therapy for early stage non bulky Hodgkins disease. Blood 98(11 Part 1): 769a, 2001

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clinical Cancer Research 12(21): 6487-6493, 2006

Definitive radiotherapy versus 2 cycles of ABVD and RT in early stage hodgkins disease Results of GHSG-trial HD7. Cancer Journal 6(2): 101, March-April, 2000

Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study. Clinical Lymphoma Myeloma and Leukemia 10(3): 181-185, 2010

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. Journal of Clinical Oncology 21(19): 3601-3608, 2003

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial. Cancer 116(17): 4054-4062, 2010